Weiss Multi-Strategy Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-24,286
| Closed | -$2.03M | – | 118 |
|
2023
Q4 | $2.03M | Sell |
24,286
-45,714
| -65% | -$3.82M | 0.05% | 331 |
|
2023
Q3 | $2.06M | Buy |
70,000
+778
| +1% | +$22.9K | 0.05% | 349 |
|
2023
Q2 | $2.26M | Buy |
69,222
+5,340
| +8% | +$174K | 0.05% | 419 |
|
2023
Q1 | $2.25M | Buy |
+63,882
| New | +$2.25M | 0.05% | 379 |
|
2020
Q4 | – | Sell |
-10,019
| Closed | -$217K | – | 655 |
|
2020
Q3 | $217K | Buy |
+10,019
| New | +$217K | 0.01% | 507 |
|
2019
Q1 | – | Sell |
-15,000
| Closed | -$95K | – | 460 |
|
2018
Q4 | $95K | Sell |
15,000
-5,095
| -25% | -$32.3K | ﹤0.01% | 355 |
|
2018
Q3 | $198K | Buy |
20,095
+95
| +0.5% | +$936 | 0.01% | 399 |
|
2018
Q2 | $166K | Sell |
20,000
-15,000
| -43% | -$125K | ﹤0.01% | 419 |
|
2018
Q1 | $252K | Sell |
35,000
-5,000
| -13% | -$36K | 0.01% | 414 |
|
2017
Q4 | $326K | Sell |
40,000
-50,000
| -56% | -$408K | 0.01% | 414 |
|
2017
Q3 | $1.31M | Buy |
90,000
+4,546
| +5% | +$65.9K | 0.05% | 295 |
|
2017
Q2 | $1.03M | Buy |
+85,454
| New | +$1.03M | 0.04% | 295 |
|
2016
Q3 | – | Sell |
-13,122
| Closed | -$125K | – | 367 |
|
2016
Q2 | $125K | Sell |
13,122
-8,878
| -40% | -$84.6K | 0.01% | 341 |
|
2016
Q1 | $155K | Buy |
22,000
+2,000
| +10% | +$14.1K | 0.01% | 377 |
|
2015
Q4 | $209K | Hold |
20,000
| – | – | 0.01% | 299 |
|
2015
Q3 | $134K | Hold |
20,000
| – | – | 0.01% | 325 |
|
2015
Q2 | $134K | Buy |
20,000
+10,000
| +100% | +$67K | 0.01% | 362 |
|
2015
Q1 | $68K | Hold |
10,000
| – | – | ﹤0.01% | 386 |
|
2014
Q4 | $80K | Buy |
+10,000
| New | +$80K | ﹤0.01% | 348 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 680 |
|
2014
Q1 | – | Sell |
-110,000
| Closed | -$715K | – | 915 |
|
2013
Q4 | $715K | Sell |
110,000
-831
| -0.7% | -$5.4K | 0.02% | 473 |
|
2013
Q3 | $839K | Sell |
110,831
-10,000
| -8% | -$75.7K | 0.02% | 391 |
|
2013
Q2 | $1.4M | Buy |
+120,831
| New | +$1.4M | 0.04% | 325 |
|